Abatacept in Steroid-Dependent Minimal Change Disease and CD80-uria

被引：11
|
作者：
Isom, Robert [1 ]
Shoor, Stanford [2 ]
Higgins, John [3 ]
Cara-Fuentes, Gabriel [4 ]
Johnson, Richard J. [5 ]
机构：
[1] Stanford Univ, Div Nephrol, Sch Med, 300 Pasteur Dr, Stanford, CA 94305 USA
[2] Stanford Univ, Div Immunol & Rheumatol, Sch Med, Stanford, CA 94305 USA
[3] Stanford Univ, Pathol, Med Ctr, Stanford, CA 94305 USA
[4] Univ Michigan, Div Pediat Nephrol, Ann Arbor, MI 48109 USA
[5] Univ Colorado, Div Renal Dis & Hypertens, Anschutz Med Campus, Aurora, CO USA
来源：
KIDNEY INTERNATIONAL REPORTS | 2019年 / 4卷 / 09期
关键词：
B7-1;
D O I：
10.1016/j.ekir.2019.05.1155
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1349 / 1353
页数：5
相关论文
共 50 条
  • [11] Rituximab therapy for steroid-dependent minimal change nephrotic syndrome
    Gilbert, Rodney D.
    Hulse, Eleanor
    Rigden, Susan
    PEDIATRIC NEPHROLOGY, 2006, 21 (11) : 1698 - 1700
  • [12] Could interleukin-17 be a therapeutic target of steroid-dependent minimal change disease?
    Kim, Ji Eun
    Shin, Jae Il
    KIDNEY INTERNATIONAL, 2013, 84 (05) : 1049 - 1049
  • [13] Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease
    Zhou, Junhua
    Zhang, Yimiao
    Liu, Gang
    Li, Jun
    Xu, Rong
    Huang, Jing
    CLINICAL NEPHROLOGY, 2013, 80 (02) : 121 - 129
  • [14] Could interleukin-17 be a therapeutic target of steroid-dependent minimal change disease? Reply
    Glassock, Richard J.
    KIDNEY INTERNATIONAL, 2013, 84 (05) : 1050 - 1050
  • [15] Effectiveness of Rituximab and Its Biosimilar in Treating Adult Steroid-Dependent Minimal Change Disease and Relapse
    Shan, Hui Yi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [16] Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults
    Jin, Li
    Lu, Wanhong
    Li, Xueying
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I704 - I704
  • [17] Mesangial myofibroblastic transformation in steroid-dependent minimal change nephrotic syndrome
    Naruse K.
    Fujieda M.
    Miyazaki E.
    Hayashi Y.
    Toi M.
    Kuroda N.
    Hiroi M.
    Kurashige T.
    Enzan H.
    Medical Electron Microscopy, 2000, 33 (2): : 102 - 107
  • [18] Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults
    Jin, Li
    Liu, Xueying
    Li, Huixian
    Dang, Xiangyun
    Wang, Zhigang
    Niu, Dan
    Zhang, Xiaotian
    Sun, Jiping
    Hao, Dapeng
    Lu, Wanhong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (08) : 1364 - 1367
  • [19] Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults
    Jin, Li
    Lu, Wanhong
    Li, Xueying
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [20] CHRONIC NEPHROTOXICITY LIMITS SUCCESSFUL USE OF TACROLIMUS IN THE MANAGEMENT OF ADULT STEROID-DEPENDENT MINIMAL CHANGE DISEASE
    Ramachandran, Raja
    Kumar, Pramod D. A.
    Nada, Ritambhra
    Jha, Vivekanand
    Gupta, Krishan Lal
    Kohli, H. S.
    NEPHROLOGY, 2015, 20 (05) : 384 - 385
12345